Cox SE - Search Results

1

Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatments.

Trindade de Almeida A, Carruthers J, Cox SE, Goldman MP, Wheeler S, Gallagher CJ. Trindade de Almeida A, et al. Among authors: cox se. Dermatol Surg. 2015 Jan;41 Suppl 1:S19-28. doi: 10.1097/DSS.0000000000000275. Dermatol Surg. 2015. PMID: 25548841

2

Development of the Facial Lines Treatment Satisfaction Questionnaire and initial results for botulinum toxin type A-treated patients.

Cox SE, Finn JC, Stetler L, Mackowiak J, Kowalski JW. Cox SE, et al. Dermatol Surg. 2003 May;29(5):444-9; discussion 449. doi: 10.1046/j.1524-4725.2003.29111.x. Dermatol Surg. 2003. PMID: 12752509

3

Social implications of hyperfunctional facial lines.

Charles Finn J, Cox SE, Earl ML. Charles Finn J, et al. Among authors: cox se. Dermatol Surg. 2003 May;29(5):450-5. doi: 10.1046/j.1524-4725.2003.29112.x. Dermatol Surg. 2003. PMID: 12752510 Review.

4

Who is still using expanded polytetrafluoroethylene?

Cox SE. Cox SE. Dermatol Surg. 2005 Nov;31(11 Pt 2):1613-5; discussion 1615. doi: 10.2310/6350.2005.31249. Dermatol Surg. 2005. PMID: 16416646

5

Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.

Fagien S, Cox SE, Finn JC, Werschler WP, Kowalski JW. Fagien S, et al. Among authors: cox se. Dermatol Surg. 2007 Jan;33(1 Spec No.):S2-9. doi: 10.1111/j.1524-4725.2006.32325.x. Dermatol Surg. 2007. PMID: 17241410 Clinical Trial.

6

Facial aesthetics: achieving the natural, relaxed look.

Carruthers A, Cohen JL, Cox SE, De Boulle K, Fagien S, Finn CJ, Flynn T, Lowe NJ, Raspaldo H, Sommer B, de Almeida AT. Carruthers A, et al. Among authors: cox se. J Cosmet Laser Ther. 2007;9 Suppl 1:6-10. doi: 10.1080/17429590701523927. J Cosmet Laser Ther. 2007. PMID: 17885880

7

Clinical experience with filler complications.

Cox SE. Cox SE. Dermatol Surg. 2009 Oct;35 Suppl 2:1661-6. doi: 10.1111/j.1524-4725.2009.01345.x. Dermatol Surg. 2009. PMID: 19807761 No abstract available.

8

Idiopathic hemifacial atrophy treated with serial injections of calcium hydroxylapatite.

Cox SE, Soderberg JM. Cox SE, et al. Dermatol Surg. 2010 Apr;36(4):542-5. doi: 10.1111/j.1524-4725.2010.01499.x. Epub 2010 Mar 2. Dermatol Surg. 2010. PMID: 20236295 No abstract available.

9

OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines.

Cohen JL, Dayan SH, Cox SE, Yalamanchili R, Tardie G. Cohen JL, et al. Among authors: cox se. Dermatol Surg. 2012 Sep;38(9):1497-505. doi: 10.1111/j.1524-4725.2012.02456.x. Epub 2012 May 23. Dermatol Surg. 2012. PMID: 22621180 Clinical Trial.

10

Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.

Fagien S, Walt JG, Carruthers J, Cox SE, Wirta D, Weng E, Beddingfield FC 3rd. Fagien S, et al. Among authors: cox se. Aesthet Surg J. 2013 Aug 1;33(6):789-98. doi: 10.1177/1090820X13495887. Epub 2013 Jul 19. Aesthet Surg J. 2013. PMID: 23873891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters